Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 230.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 420.00
  • 52 Week Low: 210.00
  • Currency: UK Pounds
  • Shares Issued: 30.62m
  • Volume: 0
  • Market Cap: £70.42m

AREC Overview

Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat™, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -555.2% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 60.7 n/a
Pr/Book 3.8  
Latest F'cast
Revenue -31.8% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

AREC Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.70 (3.51) (17.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.16 (6.95) (27.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AREC Company Announcements

BUSINESS UPDATE 19-Jan-2023 07:00 RNS
ARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA 12-Jan-2023 07:00 RNS
Grant of LTIP Options and PDMR Dealing 06-Dec-2022 16:03 RNS

AREC ShareCast News

Arecor ends 2022 in line with forecasts 19-Jan-2023 ShareCast
Arecor's Tetris launches 'Ogluo' in Austria 04-Jan-2023 ShareCast
Arecor inks formulation study deal with 'leading... 10-Nov-2022 ShareCast

Latest AREC Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

AREC Market Data

Currency UK Pounds
Share Price 230.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 420.00
52 Week Low 210.00
Volume 0
Shares Issued 30.62m
Market Cap £70.42m

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.83% below the market average46.83% below the market average46.83% below the market average46.83% below the market average46.83% below the market average
1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average
Price Trend
44.58% below the market average44.58% below the market average44.58% below the market average44.58% below the market average44.58% below the market average
12.90% above the sector average12.90% above the sector average12.90% above the sector average12.90% above the sector average12.90% above the sector average
Income Not Available
Growth
21.01% below the market average21.01% below the market average21.01% below the market average21.01% below the market average21.01% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

AREC Dividends

No dividends found

Trades for --2023

Time Volume / Share Price
0 @ 0.000p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO Susan Lowther

Top of Page